-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The new drug is a new type of chemical structure derived from natural products developed by the Company and its subsidiary Zhendong Pilot, and is mainly used for the treatment of Multiple Sclerosis (MS).
multiple sclerosis is an immune-mediated chronic inflammatory demyelinopathy disease of the central nervous system, which has high characteristics in Caucasian strains in Europe and america.
ZD03 has the same action target as MS's first-line drug fumariat, but ZD03 has higher selectivity and lower effective dose, thus providing more effective means for the clinical treatment of MS.
queryglobaldata database, global sales of fumarite in 2019 were $4.487 billion, up 3.8% year-on-year.
as of the date of this announcement, the Company has invested in research and development of zD03 new drugs at this stage is about 20.94 million yuan (unaudited).
.